These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32799573)

  • 21. Association of US Medical Marijuana Laws With Nonmedical Prescription Opioid Use and Prescription Opioid Use Disorder.
    Segura LE; Mauro CM; Levy NS; Khauli N; Philbin MM; Mauro PM; Martins SS
    JAMA Netw Open; 2019 Jul; 2(7):e197216. PubMed ID: 31314118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. United States marijuana legalization and opioid mortality epidemic during 2010-2020 and pandemic implications.
    Bleyer A; Barnes B; Finn K
    J Natl Med Assoc; 2022 Aug; 114(4):412-425. PubMed ID: 35469600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The opioid crisis: Origins, trends, policies, and the roles of pharmacists.
    Chisholm-Burns MA; Spivey CA; Sherwin E; Wheeler J; Hohmeier K
    Am J Health Syst Pharm; 2019 Mar; 76(7):424-435. PubMed ID: 31361827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combating an Epidemic of Prescription Opioid Abuse.
    Pon D; Awuah K; Curi D; Okyere E; Stern CS
    J Calif Dent Assoc; 2015 Nov; 43(11):673-8. PubMed ID: 26798885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prescription opioid abuse: Problems and responses.
    Compton WM; Boyle M; Wargo E
    Prev Med; 2015 Nov; 80():5-9. PubMed ID: 25871819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010.
    Bachhuber MA; Saloner B; Cunningham CO; Barry CL
    JAMA Intern Med; 2014 Oct; 174(10):1668-73. PubMed ID: 25154332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recreational and Medical Cannabis Legalization and Opioid Prescriptions and Mortality.
    Nguyen HV; McGinty EE; Mital S; Alexander GC
    JAMA Health Forum; 2024 Jan; 5(1):e234897. PubMed ID: 38241056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. America's Opioid Epidemic: Supply and Demand Considerations.
    Clark DJ; Schumacher MA
    Anesth Analg; 2017 Nov; 125(5):1667-1674. PubMed ID: 29049112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. United States marijuana legalization and opioid mortality trends before and during the first year of the COVID-19 pandemic.
    Bleyer A; Barnes B; Finn K
    J Opioid Manag; 2024; 20(2):119-132. PubMed ID: 38700393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methodologic limitations of prescription opioid safety research and recommendations for improving the evidence base.
    Ranapurwala SI; Naumann RB; Austin AE; Dasgupta N; Marshall SW
    Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):4-12. PubMed ID: 29862602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moving beyond misuse and diversion: the urgent need to consider the role of iatrogenic addiction in the current opioid epidemic.
    Beauchamp GA; Winstanley EL; Ryan SA; Lyons MS
    Am J Public Health; 2014 Nov; 104(11):2023-9. PubMed ID: 25211712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States.
    Chen Q; Larochelle MR; Weaver DT; Lietz AP; Mueller PP; Mercaldo S; Wakeman SE; Freedberg KA; Raphel TJ; Knudsen AB; Pandharipande PV; Chhatwal J
    JAMA Netw Open; 2019 Feb; 2(2):e187621. PubMed ID: 30707224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical cannabis laws and medical and non-medical prescription stimulant use among a nationally representative sample of US Adults: Examining the role of sexual identity and gender.
    Philbin MM; Mauro PM; Greene ER; LaBossier NJ; Giovenco DP; Martins SS
    Int J Drug Policy; 2020 Oct; 84():102861. PubMed ID: 32717704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical Marijuana Legalization in Oklahoma: Effects on Neonatal Exposure to Opiates.
    DeShea L; Rolfs S; McCoy M; Beasley WH; Szyld E; Makkar A
    Am J Perinatol; 2024 May; 41(S 01):e1069-e1074. PubMed ID: 36452967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What does the ecological and epidemiological evidence indicate about the potential for cannabinoids to reduce opioid use and harms? A comprehensive review.
    Campbell G; Hall W; Nielsen S
    Int Rev Psychiatry; 2018 Oct; 30(5):91-106. PubMed ID: 30522342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between marijuana use and nonmedical prescription opioid use in the United States: are we shifting from one epidemic to another?
    Arora P; Johnson A; Jayasekare R; Desai K
    J Public Health Policy; 2021 Jun; 42(2):310-321. PubMed ID: 33879832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationale for cannabis-based interventions in the opioid overdose crisis.
    Lucas P
    Harm Reduct J; 2017 Aug; 14(1):58. PubMed ID: 28821296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities.
    Marshall BD; Green TC; Yedinak JL; Hadland SE
    Int J Drug Policy; 2016 May; 31():25-31. PubMed ID: 26919826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework.
    Park JN; Rouhani S; Beletsky L; Vincent L; Saloner B; Sherman SG
    Milbank Q; 2020 Sep; 98(3):700-746. PubMed ID: 32808709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlates of Nonmedical Prescription Opioid Use Among U.S. Adolescents.
    Barnett TE; Thompson EL; Litt DM; Lewis MA
    Am J Prev Med; 2019 Nov; 57(5):e175-e179. PubMed ID: 31564603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.